RxDoctor Payments Data

Christine Tompkins, MD

Clinical Cardiac Electrophysiology · Aurora, CONPI 1922144500

Payments from drug & device makers

What this record shows

Medtronic accounts for 71.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,416, 4.0 times the $350 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.

$2,353in general payments, 2019–2025

Across 30 payments — averaging $78.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Biosense Webster, Inc.$234
  • Abbott$174
  • Johnson & Johnson$120
  • Boston Scientific$103
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$23
  • plus $16 from 1 others

What the payments were for

  • Travel & lodging$1,31456%
  • Food & beverage$1,03944%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,353 in reported general payments places this provider in the 15th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$239,409
Medicare patients
892
Services billed
3,427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban292$380,929
XareltoRivaroxaban46$60,049
Dofetilide70$11,872
Flecainide Acetate120$4,616
SotalolSotalol Hcl241$3,781
Dabigatran EtexilateDabigatran Etexilate Mesylate11$3,119
Metoprolol Succinate133$2,464
Colchicine24$460
Amiodarone Hcl31$454
Diltiazem 24hr Er (Cd)Diltiazem Hcl23$443
Carvedilol49$405
Spironolactone50$245
Sucralfate14$238
Metoprolol Tartrate47$167
Amlodipine Besylate21$163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$120$60,04946 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

Other clinical cardiac electrophysiology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →